Potassium excretion

Methylated Glucocorticoids. The preparation of 2a-methyl-9a- uorocortisol has been reported (76). This compound shows enhanced glucocorticoid activity and greatiy enhanced mineralocorticoid activity, so much that it surpasses aldosterone (19) ia sodium-retaining and potassium-excreting potency. Attention was then turned to the preparation of 6-methylated corticoids... 

ACE inhibitors lower the elevated blood pressure in humans with a concomitant decrease in total peripheral resistance. Cardiac output is increased or unchanged heart rate is unchanged urinary sodium excretion is unchanged and potassium excretion is decreased. ACE inhibitors promote reduction of left ventricular hypertrophy. 

Methybcanthine Diuretics. The mild diuretic effect of drinking coffee, from caffeine, and tea, mainly from theophylline, has been recogni2ed for along time. But the methylxanthines (Table 5) are of very limited efficacy when used as diuretics. The excretion of sodium and chloride ions are increased, but the potassium excretion is normal. Methylxanthines do not alter the urinary pH. Even though the methylxanthines have been demonstrated to have minor direct effects in the renal tubules, it is beUeved that they exert their diuretic effects through increased renal blood flow and GER (71). 

Patients with CKD should avoid abrupt increases in dietary intake of potassium because the kidney is unable to increase potassium excretion with an acute potassium load, particularly in latter stages of the disease. Hyperkalemia resulting... 

Sodium polystyrene sulfonate (SPS, 15 to 30 g orally), a sodium-potassium exchange resin, promotes potassium excretion from the GI tract. The onset of action is within 2 hours... 

Hyperkalemia is defined as a serum potassium concentration greater than 5 mEq/L (5 mmol/L). Manifestations of hyperkalemia include muscle weakness, paresthesias, hypotension, ECG changes (e.g., peaked T waves, shortened QT intervals, and wide QRS complexes), cardiac arrhythmias, and a decreased pH. Causes of hyperkalemia fall into three broad categories (1) increased potassium intake (2) decreased potassium excretion and (3) potassium release from the intracellular space. 

It is critically important to recognize that the treatments of hyperkalemia discussed thus far are transient, temporizing measures. They are intended to provide time to institute definitive therapy aimed at removing excess potassium from the body. Agents that increase potassium excretion from the body include sodium polystyrene sulfonate, loop diuretics, and hemodialysis or hemofiltration (used only in patients with renal failure). Sodium polystyrene sulfonate (Kayexalate , various manufacturers) can be given orally, via NG tube, or as a rectal retention enema and is dosed at 15 to 60 grams in four divided doses per day. 

Spironolactone and eplerenone block the mineralocorticoid receptor, the target site for aldosterone. In the kidney, aldosterone antagonists inhibit sodium reabsorption and potassium excretion. However, diuretic effects are minimal, suggesting that their therapeutic benefits result from other... 

Primary causes of true hyperkalemia are increased potassium intake, decreased potassium excretion, tubular unresponsiveness to aldosterone, and redistribution of potassium to the extracellular space. 

Theory Cortisol (or hydrocortisone) was introduced in the year 1951, for the treatment of rheumatoid arthritis. It has a significant effect on protein metabolism. It also exerts widespread effects on carbohydrates, lipid and protein synthesis (or anabolism). The cardinal side effects such as excessive potassium excretion and sodium retention, enhanced gastric acidity, oedema, psychosis and negative nitogen balance are some of the exaggerated manifestations of the normal metabolite functions of cortisol. 

Sodium reabsorption Much less than 10% of the filtered load of NaCl reaches the distal nephron. Regulation of Na uptake, occurring mainly in the principal cells of the cortical collecting tubule, is controlled by the steroid hormone aldosterone (see Section 4.4). The net effect of aldosterone is the reclamation of NaCl and potassium excretion in to the luminal fluid. 

Phenyluracils with alkyl groups substituted in the 5- and 6-positions, such as (L), are reported to have analgesic and antipyretic activity [376, 377]. The 1-position may also be alkylated. Such compounds are prepared by the treatment of a-alkyl-/3-aminocrotonates with phenyl isocyanate. When the 5-substituent is an isopropyl group, the resulting compound is a sodiuretic without increase in potassium excretion. 

Diuretics are drugs that increase the excretion of urine by the kidney, thereby decreasing body fluids. This alleviates the swelling of tissues that sometimes cause high blood pressure and heart, kidney, and liver failure. Furosemide is the most effective diuretic. It inhibits the readsorption of sodium in the kidney and promotes potassium excretion, two ions intimately involved in water retention for the body. It lowers blood pressure as well. The starting material for its synthesis is 2,4-dichlorobenzoic acid (formed by... 

Drugs of this group inhibit activity of carbonic anhydrase, an enzyme that catalyzes the reversible reaction of water and carbon dioxide, which forms carbonic acid. The mechanism of action of this group of drags is not fuUy understood. However, inhibition of carbonic anhydrase activity leads to a reduction of carbonic acid formation and an increase in bicarbonate, sodium, and potassium excretion with urine, which eventually leads to a significant increase in the process of excreting water from the organism. 

Note Doses greater than 25 mg/day are likely to potentiate potassium excretion but provide no further benefit in sodium excretion or blood pressure reduction. 

Another major function of the adrenal cortex is the regulation of water and electrolyte metabolism. The principal mineralocorticoid, aldosterone, can increase the rate of sodium reabsorption and potassium excretion severalfold. This will occur physiologically in response to sodium or volume depletion or both. The primary site of... 

Mecfianism of Action A guanidine derivative that acts as a potassium-sparing diuretic, antihypertensive, and antihypokalemicby directly interfering with sodium reabsorption in the distai tubule, TherapeuticEffect Increases sodium and water excretion and decreases potassium excretion. 

Mechanism of Action A potassium-sparing diuretic that inhibits sodium, potassium, ATPase. Interferes with sodium and potassium exchange in distal tubule, cortical col-lectingtubule, and collecting duct. Increases sodium and decreases potassium excretion. Also increases magnesium, decreases calcium loss. TAerapeuticEffect Produces diuresis and lowers BP. 

Trichlormethiazide is often given in combination with dexamethasone because in this way effects can be achieved with a minimum dosage of trichlormethiazide, since tire two drugs are complementary in their action. Studies in humans and experimental animals have shown that trichlormethiazide presents a favorable pattern of lower potassium excretion than the other thiazides. The clinically determined saluretic potency of trichlormethiazide was estimated to be 10-20 times lower than that of hydrochlorothiazide and 100-200 times lower than that of chlorothiazide this results in decrease in the incidence of hypokalemic manifestations. 

Acts on the distal tubules to increase potassium excretion, hydrogen ion excretion, and sodium reabsorption and subsequent water retention... 

Mineralocorticoids are involved in controlling electtolyte and fluid levels.9,44 The primary mineralo-corticoid produced by the adrenal cortex is aldosterone. Aldosterone increases the reabsorption of sodium from the renal tubules. By increasing sodium reabsorption, aldosterone facilitates the reabsorption of water. Aldosterone also inhibits the renal reabsorption of potassium, thus increasing potassium excretion. Mineralocorticoid release is regulated by fluid and electrolyte levels in the body and by other hormones, such as the renin-angiotensin system. 

Mineralocorticoids are also steroid hormones that are produced by the adrenal cortex. The principal mineralocorticoid in humans is aldosterone. Aldosterone is primarily involved in maintaining fluid and electrolyte balance in the body. This hormone works on the kidneys to increase sodium and water reabsorption and potassium excretion. 

In addition to the angiotensin II effects, aldosterone secretion is regulated by increased plasma potassium levels.75,83 Presumably, elevated plasma potassium serves as a stimulus to increase aldosterone release, thus causing increased potassium excretion and a return to normal plasma levels. Finally, there is evidence that ACTH may also play a role in aldosterone release. Although ACTH is primarily involved in controlling glucocorticoid secretion, this hormone may also stimulate mineralocorticoid release to some extent.75... 

Mineralocorticoids are believed to increase sodium reabsorption by affecting sodium channels and sodium pumps on the epithelial cells lining the renal tubules.18,58 Mineralocorticoids ability to increase the expression of sodium channels is illustrated in Figure 29-5. These hormones enter the tubular epithelial cell, bind to receptors in the cell, and create an activated hormone-receptor complex.18 This complex then travels to the nucleus to initiate transcription of messenger RNA units, which are translated into specific membrane-related proteins.27,58 These proteins in some way either create or help open sodium pores on the cell membrane, thus allowing sodium to leave the tubule and enter the epithelial cell by passive diffusion.27,83 Sodium is then actively transported out of the cell and reabsorbed into the bloodstream. Water reabsorption is increased as water follows the sodium movement back into the bloodstream. As sodium is reabsorbed, potassium is secreted by a sodium-potassium exchange, thus increasing potassium excretion (see Fig. 29-5). 

Hypokalemia eventually develops in many patients who are placed on loop diuretics or thiazides. This can often be managed with dietary NaCl restriction. When hypokalemia cannot be managed in this way, or with dietary KC1 supplements, the addition of a potassium-sparing diuretic can significantly lower potassium excretion. While this approach is generally safe, it should be avoided in patients with renal insufficiency in whom life-threatening hyperkalemia can develop in response to potassium-sparing diuretics. 

Renal plasma flow and glomerular filtration rate are usually unaffected, but free water clearance may increase. Because most sodium is reabsorbed in the proximal renal tubules, spironolactone is relatively ineffective when administered alone. Concomitant administration of a diuretic which blocks re-absorption of sodium proximal to the distal portion of the nephron (such as a thiazide or loop diuretic) is required for maximum diuretic effects. When administered with other diuretics, spironolactone produces an additive or synergistic diuretic response and decreases potassium excretion caused by the other diuretic [65],... 

Aspirin has been shown to slightly reduce the natriuretic effect of spironolactone in healthy individuals, possibly by reducing active renal tubular secretion of canrenone, the active metabolite of spironolactone. However, the hypotensive effect of spironolactone and its effect on urinary potassium excretion in hypertensive patients is apparently not affected. Until more clinical data are available on this potential interaction, patients receiving both drugs should be monitored for signs and symptoms of decreased clinical response to spironolactone [65]. 

---